Principles of appropriate antibiotic use for treatment of uncomplicated acute bronchitis: Background

Annals of Emergency Medicine

Volumn 37, Issue 6, 2001, Pages 720-727

  Gonzales, Ralph ^a   Bartlett, John G ^b   Besser, Richard E ^c   Cooper, Richelle J ^d   Hickner, John M ^e   Hoffman, Jerome R ^d   Sande, Merle A ^f  

^a UNIVERSITY OF COLORADO   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e MICHIGAN STATE UNIVERSITY   (United States)

^f UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; DOXYCYCLINE; ERYTHROMYCIN; LIDAPRIM;

ANTIBIOTIC THERAPY; ARTICLE; BRONCHITIS; CLINICAL TRIAL; COUGHING; DIAGNOSTIC TEST; DRUG USE; HUMAN; INFLUENZA; PATIENT CARE; PATIENT SATISFACTION; PERTUSSIS; PNEUMONIA; PRIORITY JOURNAL; THORAX RADIOGRAPHY;

EID: 0035004522     PISSN: 01960644     EISSN: None     Source Type: Journal    
DOI: 10.1067/S0196-0644(01)70091-1     Document Type: Article

References (75)

1. Clinical syndromes in adults caused by respiratory infection
2. Diagnosis of acute bronchitis in adults: A national survey of family physicians
3. What's in a name? Public knowledge, attitudes, and experiences with antibiotic use for acute bronchitis
4. Principles of appropriate antibiotic use for treatment of acute respiratory tract infections in adults: Background, specific aims, and methods
5. Managing cough as a defense mechanism and as a symptom. A consensus panel report of the American college of chest physicians
6. National trends in the use of antibiotics by primary care physicians for adult patients with cough
7. Pulmonary function tests in acute bronchitis: Evidence for reversible airway obstruction
8. Reversible airflow limitation in adults with respiratory infection
9. Acute bronchitis in the community: Clinical features, infective factors, changes in pulmonary function and bronchial reactivity to histamine
10. Cough variant asthma: A review of the clinical literature
11. Cough-variant asthma in children and adults: Case reports and review
12. Prediction of pneumonia in outpatients with acute cough - A statistical approach
13. Clinical prediction rule for pulmonary infiltrates
14. Clinical criteria for the detection of pneumonia in adults: Guidelines for ordering chest roentgenograms in the emergency department
15. Decision rules and clinical prediction of pneumonia: Evaluation of low-yield criteria
16. Comparison of physician judgment and decision aids for ordering chest radiographs for pneumonia in outpatients
17. Does this patient have community-acquired pneumonia? Diagnosing pneumonia by history and physical examination
18. Colour of respiratory discharge and antibiotic use
19. Patient knowledge of upper respiratory infections: Implications for antibiotic expectations and unnecessary utilization
20. The relation between purulent manifestations and antibiotic treatment of upper respiratory tract infections
21. Green sputum
22. Adult bacterial nasopharyngitis: A clinical entity?
23. Influence of age on symptoms at presentation in patients with community-acquired pneumonia
24. Risk factors for 30-day mortality in elderly patients with lower respiratory tract infection. Community-based study
25. A new Chlamydia psittaci strain, TWAR, isolated in acute respiratory tract infections
26. Evidence that Chlamydia pneumoniae causes pneumonia and bronchitis
27. Acute bronchitis in adults. Clinical findings, microorganisms and use of antibiotics
28. Prospective study of aetiology and outcome of adult lower-respiratory-tract infections in the community
29. Acute viral infections of upper respiratory tract in elderly people living in the community: Comparative, prospective, population based study of disease burden
30. Acute bronchitis in adults. How close do we come to its aetiology in general practice?
31. Pertussis infection in adults with persistent cough
32. Prevalence of positive serology for acute Chlamydia pneumoniae infection in emergency department patients with persistent cough
33. Prevalence and incidence of adult pertussis in an urban population
34. Randomised controlled trial of antibiotics in patients with cough and purulent sputum
35. Effectiveness of erythromycin in the treatment of acute bronchitis
36. A randomized, controlled trial of doxycycline in the treatment of acute bronchitis
37. Effects of doxycycline in patients with acute cough and purulent sputum: A double blind placebo controlled trial
38. Erythromycin in the treatment of acute bronchitis in a community practice
39. The treatment of acute bronchitis with trimethoprim and sulfamethoxazole
40. A placebo-controlled, double-blind trial of erythromycin in adults with acute bronchitis
41. Double-blind trial of early demethylchlortetracycline in minor respiratory illness in general practice
42. Doxycycline in acute bronchitis: A randomized double-blind trial
43. Randomized placebo-controlled trials of antibiotics for acute bronchitis: A critical review of the literature
44. Treatment of acute bronchitis in adults without underlying lung disease
45. Quantitative systematic review of randomised controlled trials comparing antibiotic with placebo for acute cough in adults
46. Are antibiotics effective treatment for acute bronchitis? A meta-analysis
47. Antibiotics in acute bronchitis: A meta-analysis
48. Pertussis in the 1990s: Diagnosis, treatment, and prevention
49. Factors influencing the spread of pertussis in households
50. Prevention of secondary transmission of pertussis in households with early use of erythromycin
51. Erythromycin in the treatment of pertussis: A study of bacteriologic and clinical effects
52. Successful treatment of naturally occurring influenza A/USSR/77 H1N1
53. Therapeutic efficacy of amantadine HCl and rimantadine HCl in naturally occurring influenza A2 respiratory illness in man
54. Neuraminidase inhibitors for treatment of influenza A and B infections
55. Neuraminidase inhibitors for preventing and treating influenza in healthy adults
56. Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenza virus infections
57. Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenza A and B virus infections
58. Randomised trial of efficacy and safety of inhaled zanamivir in treatment of influenza A and B virus infections
59. Performance of virus isolation and directigen flu A to detect influenza A virus in experimental human infection
60. Optical immunoassay test for rapid detection of influenza A and B viruses: An evaluation
61. Comparison of a new neuraminidase detection assay with an enzyme immunoassay, immunofluorescence, and culture for rapid detection of influenza A and B viruses in nasal wash specimens
62. A comparison of albuterol and erythromycin for the treatment of acute bronchitis
63. Albuterol delivered by metered-dose inhaler to treat acute bronchitis
64. Symptomatic effect of inhaled fenoterol in acute bronchitis: A placebo-controlled double-blind study
65. Antibiotics and respiratory infections: Are patients more satisfied when expectations are met?
66. Decreasing antibiotic use in ambulatory practice: Impact of a multidimensional intervention on the treatment of uncomplicated acute bronchitis in adults
67. Reducing antibiotic use in ambulatory practice: Impact on patient-centered outcomes